1. Home
  2. RVPH vs GDHG Comparison

RVPH vs GDHG Comparison

Compare RVPH & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • GDHG
  • Stock Information
  • Founded
  • RVPH 2006
  • GDHG 2008
  • Country
  • RVPH United States
  • GDHG China
  • Employees
  • RVPH N/A
  • GDHG N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • RVPH Health Care
  • GDHG Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • RVPH 18.1M
  • GDHG 19.4M
  • IPO Year
  • RVPH N/A
  • GDHG 2023
  • Fundamental
  • Price
  • RVPH $0.68
  • GDHG N/A
  • Analyst Decision
  • RVPH Strong Buy
  • GDHG
  • Analyst Count
  • RVPH 6
  • GDHG 0
  • Target Price
  • RVPH $4.50
  • GDHG N/A
  • AVG Volume (30 Days)
  • RVPH 16.9M
  • GDHG 15.4K
  • Earning Date
  • RVPH 11-13-2025
  • GDHG 07-11-2025
  • Dividend Yield
  • RVPH N/A
  • GDHG N/A
  • EPS Growth
  • RVPH N/A
  • GDHG N/A
  • EPS
  • RVPH N/A
  • GDHG N/A
  • Revenue
  • RVPH N/A
  • GDHG $16,666,899.00
  • Revenue This Year
  • RVPH N/A
  • GDHG N/A
  • Revenue Next Year
  • RVPH N/A
  • GDHG N/A
  • P/E Ratio
  • RVPH N/A
  • GDHG N/A
  • Revenue Growth
  • RVPH N/A
  • GDHG N/A
  • 52 Week Low
  • RVPH $0.25
  • GDHG $2.40
  • 52 Week High
  • RVPH $4.28
  • GDHG $1,968.41
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 65.12
  • GDHG 61.59
  • Support Level
  • RVPH $0.29
  • GDHG $7.18
  • Resistance Level
  • RVPH $0.86
  • GDHG $7.72
  • Average True Range (ATR)
  • RVPH 0.07
  • GDHG 0.30
  • MACD
  • RVPH 0.05
  • GDHG -0.25
  • Stochastic Oscillator
  • RVPH 72.03
  • GDHG 58.90

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: